Silent but persistent: Failure of continuous tenofovir based ART to prevent HBV and HDV reactivation under chemotherapy in an HBsAg-negative patient living with HIV.
Silent but persistent: Failure of continuous tenofovir based ART to prevent HBV and HDV reactivation under chemotherapy in an HBsAg-negative patient living with HIV.
Pflüger, Giersch + more
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.